Invitae (NYSE:NVTA – Get Rating) announced its quarterly earnings data on Tuesday. The medical research company reported ($0.78) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.76) by ($0.02), MarketWatch Earnings reports. The company had revenue of $123.70 million during the quarter, compared to analysts’ expectations of $129.31 million. Invitae had a […]
Wall Street analysts expect Invitae Co. (NYSE:NVTA – Get Rating) to report sales of $126.72 million for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for Invitae’s earnings. The highest sales estimate is $127.95 million and the lowest is $125.30 million. Invitae reported sales of $103.62 million in the same quarter […]
Invitae (NYSE:NVTA – Get Rating) and American Shared Hospital Services (NYSE:AMS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, dividends, valuation, earnings, profitability and analyst recommendations. Insider and Institutional Ownership 90.6% of Invitae shares […]
Brokerages expect Invitae Co. (NYSE:NVTA – Get Rating) to report sales of $130.38 million for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Invitae’s earnings, with estimates ranging from $125.30 million to $138.81 million. Invitae posted sales of $103.62 million during the same quarter last year, which suggests a […]
Strs Ohio cut its holdings in Invitae Co. (NYSE:NVTA – Get Rating) by 80.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 4,500 shares of the medical research company’s stock after selling 18,900 shares during the period. Strs Ohio’s holdings in Invitae were worth $68,000 as of its most recent SEC filing. […]